
يتطور
صحة·2 g önceملخص الذكاء الاصطناعي
新分子UNI418有望克服癌症標靶藥物抗藥性
南韓研究團隊發現新分子UNI418,能削弱癌細胞DNA修復能力,並與標靶藥物奧拉帕利合併使用,使已產生抗藥性的癌細胞恢復敏感度,有望克服癌症治療的抗藥性問題。
自
自由时报
南韓研究團隊發現新分子UNI418,能削弱癌細胞DNA修復能力,並與標靶藥物奧拉帕利合併使用,使已產生抗藥性的癌細胞恢復敏感度,有望克服癌症治療的抗藥性問題。

A 72-year-old man in Taiwan with advanced bladder cancer has had his tumor significantly shrink and avoid full bladder removal thanks to a new treatment combining targeted therapy (EV) and immunotherapy. This approach shows an 80% efficacy rate, a major improvement over traditional methods.